LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹202 Cr |
| Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -19.47 | |
| Mar2023 | ₹130 Cr | -5.51 | |
| Mar2022 | ₹137 Cr | -32.24 | |
| Mar2021 | ₹202 Cr | 21.00 | |
| Mar2020 | ₹167 Cr | - | |
Compare Revenue of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹45.1 Cr | 1.1% | -13.3% | -66% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 1.1% |
-13.3% |
-66% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses